Scholarship table
> all known novel coronavirus strainsSo they're saying they can eliminate the common cold?
Liberty University refused mask mandates, vaccine mandates, and social distancing rules. We’re still in August and the whole school is already in quarantine. Classes online, no eating in cafeteria, etc. Falwell jr. has even had to put in a camera so he can watch his wife and the cabana boy from another room.
If we just stop counting covid deaths, the numbers will go down!Florida changed its COVID-19 data, creating an ‘artificial decline’ in recent deathshttps://www.miamiherald.com/news/coronavirus/article253796898.htmlAs cases ballooned in August, however, the Florida Department of Health changed the way it reported death data to the CDC, giving the appearance of a pandemic in decline, an analysis of Florida data by the Miami Herald and el Nuevo Herald found.On Monday, Florida death data would have shown an average of 262 daily deaths reported to the CDC over the previous week had the health department used its former reporting system, the Herald analysis showed. Instead, the Monday update from Florida showed just 46 “new deaths” per day over the previous seven days.
maybe they'll give the grope gov's emmy to the "d' man eyn'a?
I see a news blurb that Connecticut hospitals are taking out of state COVID patients.
I’m good with DeSantis following Cuomo’s lead. He should. Both are bad. See how easy that is?
The common cold is a rhinovirus, not a coronavirus, but I'm just being pedantic.
sorry doctor hards, but... 10-40% are caused by rhinovirus 20% coronovirus 20% rsv and parainfluenzahttps://www.webmd.com/cold-and-flu/cold-guide/common_cold_causes
From the Charlotte Observer:Charlotte-area doctors issued dire warnings ahead of Labor Day weekend travel and gatherings, urging North Carolinians to get the COVID-19 vaccine amid a surge in coronavirus cases, hospitalizations and even deaths.
Comments or thoughts from the sciencers?This new antibody can stop all COVID-19 strains, including new variants, experts sayhttps://www.deseret.com/coronavirus/2021/8/27/22643254/antibody-stops-covid-19-coronavirus-variants-delta-lambda"A team of researchers may have found an antibody that can neutralize all known novel coronavirus strains, including the developing variants.GlaxoSmithKline and Vir Biotechnology recently conducted a huge collaborative study by scientists and developed a new antibody therapy, called Sotrovimab. During the project, they discovered a new natural antibody “that has remarkable breadth and efficacy,” according to the Berkeley Lab."
Just seeing this now, as I've been a bit busy the last week. A couple general thoughts, and comments to clarify what has been done. First...no, nowhere near a cure for the common cold (even those caused by coronaviruses). These new antibodies are only specific to a clade of beta-coronaviruses closely related to SARS and SARS-COV2. The epitopes recognized by these antibodies are not conserved in other coronaviruses. Second...this is not actually new news, the existence of these broadly effective neutralizing antibodies has been known and studied for awhile. What was new, and why there is now a new article, is that researchers were able to better understand the mechanism of action of some of these very broad-spectrum antibodies. So a general question may be, if we knew of these, why haven't we been scaling them up as pharmaceuticals. We definitely can produce these on scale, but have largely not went down this road, because the focus for monoclonal antibodies has been on antibodies that demonstrate extremely potent neutralizing capacity.In general, there is a tradeoff in getting more breadth in coverage (broader spectrum) and neutralizing potency; these are generally inversely correlated. So a potent monoclonal antibody will be significantly less potent. The new research shows two things. 1) That there may be intermediate options, where you see an increase in breadth and still pretty high potency. In light of the number of escape variants out there now, a shift in focus to these types of antibodies might be warranted. Especially since it appears that viral mutations escaping these antibodies are rare, and appear to lead to less infectious strains. 2) They now understand the mechanism of action for antibodies with wide breadth. These typically target a region neglected in current pharmaceutical design, which means we might be able to design more potent versions that retain broad efficacy across the SARS-like virus family (sarbecoviruses). So no magic bullet yet, but moving in the right direction. In addition, the number of new doors this research is opening will lead to countless new developments on treatments for many diseases, not just COVID.In the meantime, science will keep on sciencing.